A detailed history of First American Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First American Bank holds 614 shares of VRTX stock, worth $252,139. This represents 0.02% of its overall portfolio holdings.

Number of Shares
614
Previous 614 -0.0%
Holding current value
$252,139
Previous $288 Million 0.78%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$392.81 - $485.53 $241,185 - $298,115
614 New
614 $288 Million
Q3 2023

Jul 31, 2024

BUY
$338.18 - $362.46 $5,072 - $5,436
15 Added 2.5%
614 $213,000
Q2 2023

Jul 31, 2024

SELL
$314.42 - $351.91 $4,716 - $5,278
-15 Reduced 2.44%
599 $210,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track First American Bank Portfolio

Follow First American Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First American Bank, based on Form 13F filings with the SEC.

News

Stay updated on First American Bank with notifications on news.